Nukkleus Inc. Receives Shareholder Approval to Acquire Star 26 Capital Inc.
Nukkleus (NASDAQ: NUKK) received stockholder approval to acquire 100% of Star 26 Capital, with the transaction expected to close before December 31, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Nukkleus (NASDAQ: NUKK) received stockholder approval to acquire 100% of Star 26 Capital, with the transaction expected to close before December 31, 2025. Consideration will be a mixed package of cash, equity, and promissory notes plus Nukkleus shares and warrants, subject to customary adjustments. The deal, first announced on December 15, 2024, adds Star 26’s defense portfolio including B. Rimon Agencies and a majority interest in Water.io (TASE: WATR), and is intended to strengthen Nukkleus across the military UAV/UAS value chain projected at ~$23 billion by 2030.
Stockholders also approved conversion-related share issuances and share issuances tied to a $250 million equity line.
Positive
- Acquisition of 100% of Star 26 to expand defense portfolio
- Adds B. Rimon Agencies distribution relationships with major defense contractors
- Majority interest in Water.io (TASE: WATR) and convertible position in ITS/Positech
- Expected to strengthen position across military UAV/UAS value chain (~$23B by 2030)
- Potential operational efficiencies via shared resources and cross-platform integration
Negative
- Consideration includes promissory notes, adding creditor obligations
- Stockholder approval allows conversion-related share issuance, which may dilute existing equity
- Approved issuance of shares tied to a $250 million equity line, creating further potential dilution
Details
News Market Reaction – NUKK
On Dec 18, the first trading day after this news, NUKK closed 8.38% below the previous close.
Data tracked by StockTitan Argus for the Dec 18 session.
Key Figures
- Star 26 ownership
- 100%
- Ownership of Star 26 Capital Inc. upon closing
- UAV/UAS market size
- approximately $23 billion
- Expected UAV and UAS value chain by 2030
- Expected closing date
- Before December 31, 2025
- Target timing for Star 26 acquisition closing
- Initial announcement date
- December 15, 2024
- Original announcement of Star 26 transaction
- Shareholder meeting date
- December 16, 2025
- Special Meeting of Stockholders approving acquisition
- Equity line size
- $250 million
- Equity line associated with approved share issuance
Historical Context
-
Closing of SC II SPAC IPO raising $172.5M in gross proceeds.
-
Pricing of SC II SPAC units at $10.00 targeting $150M raise.
-
Announcement of special meeting to approve 100% Star 26 acquisition.
-
Highlighting Rimon and Iron Dome demand under a large U.S. aid package.
-
Milipol Paris 2025 exhibit of integrated A&D and AI technologies.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
uav technical
uas technical
artificial intelligence technical
gnss technical
warrants financial
convertible preferred stock financial
equity line financial
promissory notes financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK and TEL AVIV, Israel, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Nukkleus Inc. (NASDAQ: NUKK) (“Nukkleus” or the “Company”), a strategic acquirer and developer of high-potential businesses in the aerospace and defense (A&D) industry, today announced that its stockholders have approved the acquisition of Star 26 Capital Inc., a defense-focused acquisition company. The transaction is expected to close before December 31, 2025.
Pursuant to the approved transaction, Nukkleus is expected to acquire
The transaction, which was first announced on December 15, 2024, was approved by Nukkleus stockholders at the Special Meeting of Stockholders held on December 16, 2025, is intended to provide Nukkleus with
Upon closing, the acquisition is expected to significantly enhance Nukkleus’s position across the military UAV and UAS value chain, which is expected to reach approximately
Star 26 brings to Nukkleus a portfolio of defense and technology companies that are complementary to unmanned and autonomous systems, including B. Rimon Agencies Ltd., a leading Israeli supplier of critical components for advanced missile-defense such as the Iron Dome, with exclusive distribution relationships with major defense contractors including Rafael Advanced Defense Systems and Elbit Systems. Star 26 also holds a majority interest in Water.io (TASE: WATR), which recently completed its acquisition of Zorronet, a developer of AI-powered unmanned command centers and integrated physical-security platforms, as well as a convertible loan position in ITS/Positech, a specialist in advanced motion-control, stabilization, and targeting technologies.
These companies are expected to collaborate with Nukkleus’s existing portfolio across AI, UAVs, aerospace systems, command and control, and defense infrastructure, supporting integrated solutions that combine autonomous platforms with motion, sensing, and centralized control. Following the closing, the acquisition is expected to provide operational efficiencies through shared resources, streamlined supply chains, expanded distribution, and cross-platform integration, while each subsidiary continues to operate independently within its core domain. This approach supports Nukkleus’s ability to address evolving requirements in UAV, UAS, and related defense systems.
“We are very pleased to have received stockholder approval for this acquisition,” said Menny Shalom, CEO of Nukkleus Inc. “This transaction is the next logical step for Nukkleus, as unmanned and autonomous systems become an integral part of modern defense, performance increasingly depends on how well hardware, control systems, and software work together. Bringing Star 26 and its portfolio under the Nukkleus umbrella enables closer collaboration across AI, UAVs, aerospace systems, and command and control, supporting integrated solutions that combine autonomy with motion and sensing. For shareholders, this structure is expected to improve operational efficiency through shared resources and coordinated supply chains, while positioning Nukkleus to address evolving requirements in UAS and related defense programs in a disciplined way.”
At the special meeting, stockholders of the Company’s Common Stock also approved the issuance of shares upon conversion of the Company’s outstanding Series A Convertible Preferred Stock and associated warrants previously issued to investors, as well as the issuance of shares in connection with the Company’s
About Nukkleus Inc.
Nukkleus Inc. (NASDAQ: NUKK) focuses on acquiring and scaling mission-critical suppliers across the defense, aerospace, and advanced manufacturing sectors. Nukkleus targets Tier 2 and Tier 3 companies that form the industrial backbone of national security infrastructure in the U.S., Israel, and Europe. Through its proprietary capital model, Nukkleus integrates operational capabilities, financial discipline, and long-term vision to modernize and expand strategic suppliers—supporting dual-use innovation and resilient supply chains.
The Company's portfolio approach combines organic growth with disciplined M&A, enabling transformational scale and positioning Nukkleus at the core of 21st-century defense industrial strategy.
Forward-Looking Statements
This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts are "forward-looking statements" within the meaning of federal securities laws. In some cases, you can identify forward-looking statements by terminology such as "will," "would," "expect," "intend," "plan," "objective," or comparable terminology referencing future events, conditions or circumstances, or the negative of such terms.
Although Nukkleus believes that it has a reasonable basis for the forward-looking statements contained in this press release, they are based on management's current beliefs and expectations about future events and circumstances and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond the Company's control. Statements relating to the future performance of Nukkleus are subject to many factors including but not limited to: the Company's ability to successfully integrate Star 26 and realize the anticipated benefits of the acquisition; the sufficiency of working capital to realize our business plans and strategic opportunities; the going concern qualification in our financial statements; our ability to penetrate new intended markets; the Company's ability to retain key personnel; market acceptance of our products and services; changes in the defense industry and government spending; geopolitical risks; competition; the Company's ability to access capital markets; and general economic conditions.
Risk factors described under "Risk Factors" in Nukkleus' most recently filed annual report on Form 10-K, as updated from time to time in its quarterly reports on Form 10-Q and other filings with the Securities and Exchange Commission, may cause actual results, performance or achievements to differ materially from those expressed or implied by forward-looking statements in this press release. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they were made. Nukkleus undertakes no obligation to update any forward-looking statement contained in this press release to reflect events that occur or circumstances that exist after the date of this press release, except as required by law.
Investor Relations Contact:
The Equity Group Inc.
Lena Cati
lcati@equityny.com
+1 (212) 836-9611
Val Ferraro
vferraro@theequitygroup.com
+1 (212) 836-9633
Company Contact:
Nukkleus Inc.
575 Fifth Avenue, 14th Floor
New York, New York 10017
info@nukk.com
+1 (212) 791-4663
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.